Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rose

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
Muscle & Nerve|December 31, 2024
Long-Term Outcomes From a Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) Compared to Standard Medical Care for Improving Quality of Life in Muscle DisordersChristopher D Graham, Michael Rose, Victoria Edwards, et al.
Psychological Medicine|February 22, 2022
A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseasesMichael Rose, Christopher D Graham, Nicola O'Connell, et al.
Scientific Reports|April 18, 2025
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancerJulia Pannhausen, Julia Wirtz, Klaus Mantwill, et al.
Frontiers in Psychology|December 18, 2023
Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trialVictoria Edwards, Chiara Vari, Michael Rose, et al.
Oncotarget|September 28, 2016
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroupPhilipp H Baldia, Angela Maurer, Timon Heide, et al.
Epigenetics|September 15, 2016
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patientsMartin Schlensog, Lara Magnus, Timon Heide, et al.
American Journal of Physiology. Renal Physiology|February 17, 2012
A role for the organic anion transporter OAT3 in renal creatinine secretion in miceVolker Vallon, Satish A Eraly, Satish Ramachandra Rao, et al.
Carcinogenesis|November 23, 2013
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumoursMichael Rose, Nadine T Gaisa, Pia Antony, et al.
BMJ Open|May 28, 2024
A qualitative exploration of challenges recruiting older adults for <i>Being Your Best,</i> a co-designed holistic intervention to manage and reduce frailty: lessons learnt amidst the COVID-19 pandemic in Melbourne, AustraliaAhsan Saleem, Arti Appannah, Claudia Meyer, et al.
Pediatric Radiology|June 29, 2016
Evaluation of blood flow distribution asymmetry and vascular geometry in patients with Fontan circulation using 4-D flow MRIKelly Jarvis, Susanne Schnell, Alex J Barker, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Muscle & Nerve|December 31, 2024
Long-Term Outcomes From a Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) Compared to Standard Medical Care for Improving Quality of Life in Muscle DisordersChristopher D Graham, Michael Rose, Victoria Edwards, et al.
Psychological Medicine|February 22, 2022
A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseasesMichael Rose, Christopher D Graham, Nicola O'Connell, et al.
Scientific Reports|April 18, 2025
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancerJulia Pannhausen, Julia Wirtz, Klaus Mantwill, et al.
Frontiers in Psychology|December 18, 2023
Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trialVictoria Edwards, Chiara Vari, Michael Rose, et al.
Oncotarget|September 28, 2016
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroupPhilipp H Baldia, Angela Maurer, Timon Heide, et al.
Epigenetics|September 15, 2016
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patientsMartin Schlensog, Lara Magnus, Timon Heide, et al.
American Journal of Physiology. Renal Physiology|February 17, 2012
A role for the organic anion transporter OAT3 in renal creatinine secretion in miceVolker Vallon, Satish A Eraly, Satish Ramachandra Rao, et al.
Carcinogenesis|November 23, 2013
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumoursMichael Rose, Nadine T Gaisa, Pia Antony, et al.
BMJ Open|May 28, 2024
A qualitative exploration of challenges recruiting older adults for <i>Being Your Best,</i> a co-designed holistic intervention to manage and reduce frailty: lessons learnt amidst the COVID-19 pandemic in Melbourne, AustraliaAhsan Saleem, Arti Appannah, Claudia Meyer, et al.
Pediatric Radiology|June 29, 2016
Evaluation of blood flow distribution asymmetry and vascular geometry in patients with Fontan circulation using 4-D flow MRIKelly Jarvis, Susanne Schnell, Alex J Barker, et al.
Pageof 23